title: Pretreatment of patients with atrial fibrillation who undergo electrical cardioversion.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Stabile
authors.forename: Pietro
authors.initials: P
authors.lastname: Turco
authors.forename: Antonio
authors.initials: A
authors.lastname: De Simone
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000628:therapy*; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D004554:Electric Countershock; D006801:Humans; D000077405:Irbesartan; D055502:Secondary Prevention; D013777:Tetrazoles / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001713:Biphenyl Compounds; D002121:Calcium Channel Blockers; D013777:Tetrazoles; D000077405:Irbesartan; D000638:Amiodarone